- Reaction score
- 2,035
The problem comes down to risk vs. reward and what each one of us finds to be acceptable as a risk in exchange for hair. Admittedly, the better the hair, the more willing I am to take on some level of extra risk but I also believe that HRT maintenance is effective maybe down to 100 pg/ml as you mention.Placebo effects are strong however there might be some advantage for some MTF to have elevated E2 at least for some time, it's not well studied.
In any case Almas isn't an MTF and shouldn't try to go for experimental feminizing protocols at least initially. If removing DHT while lowering T and increasing E2 to a maximum of 100pg/ml doesn't give significant improvements after a year anything else isn't likely to help.
If no breast growth is a prerequisite, then those guys should not even bother to try HRT. You cannot sweat breast growth in my opinion if you want to be successful. Maybe we will have better protocols going forward with Serms but they are expensive and far from foolproof and they might not be good for hair. Perhaps having developed breasts is good for hair and perhaps having little to no beard growth is good for hair so the beard guys shouldn't attempt this either.
It is difficult still to pinpoint the mechanism by which HRT commences regrowth. Is having zero T enough to regrow hair? Probably not so we still need some therapeutic level of estradiol ingestion for hair regrowth and for feminization in general, if that is the goal. But once someone starts saying that they can't have breasts or any increase in body fat or any lessening of beard growth and so on, more and more is being changed from the standard XX hair growth vehicle.
It appeared to me that not a single person on this thread except for Bridge or maybe only a few, have the knowledge and the experience to know what they are doing to the extent that they can micro-manage bodily adjustments. Trying to avoid breast growth might just induce more breast growth. So the only real option is to quit immediately upon seeing breast growth. Titrating downward is not likely to even remotely work until we get down to non-therapeutic doses.